Glenmark gets USFDA nod for skin ointment
Glenmark has been granted final approval by the USFDA for Tacrolimus ointment USP
New Delhi: Glenmark Pharmaceuticals on Wednesday said it has received final approval from the US health regulator for Tacrolimus ointment used for treating atopic dermatitis (eczema).
Glenmark Pharmaceuticals Inc. USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus ointment USP, 0.1%, the company said in a BSE filing. The product is a generic version of Protopic ointment, of Leo Pharma AS in the same strength, it added.
According to IQVIA sales data for the 12-month period ending February 2018, Protopic ointment 0.11% achieved annual sales of around $109 million, Glenmark Pharmaceuticals said.
The company’s current portfolio consists of 132 products authorised for distribution in the US market and 61 Abbreviated New Drug Applications (ANDA’s) pending approval with the USFDA, it added.
Shares of Glenmark Pharmaceuticals were trading at Rs576 per scrip on the BSE, up 0.38%, from the previous close.
- How do bank frauds happen? Central Vigilance Commission has the answers
- Why India lags peers in digital payments
- Paytm CEO Vijay Shekhar Sharma’s secretary arrested for blackmailing him
- IL&FS revival plan could include stake sales: Report
- Hero MotoCorp forays into 125-cc scooter segment with Destini 125
Editor's Picks »
- Tata Steel to sell stake in South African mine for $25.6 million
- Bank FDs vs gold vs stocks: How much you would have earned
- In Pics: World’s longest sea bridge - connecting China, Hong Kong
- Markets LIVE: Sensex falls 200 points, Nifty below 10,200; Asian Paints down 5%
- How concentrated is your mutual fund portfolio
- Hindustan Zinc dividend payout offsets dull Q2 results
- Q2 results no blockbuster for Inox Leisure as margins disappoint
- NBFC scare shaves 8.5% of IndusInd Bank share price
- Q2 results portent a dull Diwali for paint stocks investors
- Reliance Jio seen overtaking Vodafone Idea, Airtel to become India’s largest telecom firm by 2018-end